• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TPAD-MBR系统在基于化学合成的制药废水试点处理中的新应用。

A novel application of TPAD-MBR system to the pilot treatment of chemical synthesis-based pharmaceutical wastewater.

作者信息

Chen Zhaobo, Ren Nanqi, Wang Aijie, Zhang Zhen-Peng, Shi Yue

机构信息

Research Center of Environmental Biotechnology, 2614#, School of Municipal and Environmental Engineering, Harbin Institute of Technology, 202 Haihe Road, Harbin, PR China.

出版信息

Water Res. 2008 Jul;42(13):3385-92. doi: 10.1016/j.watres.2008.04.020. Epub 2008 May 3.

DOI:10.1016/j.watres.2008.04.020
PMID:18538367
Abstract

A pilot-scale test was conducted with a two-phase anaerobic digestion (TPAD) system and a subsequential membrane bioreactor (MBR) treating chemical synthesis-based pharmaceutical wastewater. The TPAD system comprised a continuous stirred tank reactor (CSTR) and an upflow anaerobic sludge blanket-anaerobic filter (UASBAF), working as the acidogenic and methanogenic phases, respectively. The wastewater was high in COD, varying daily between 5789 and 58,792 mg L(-1), with a wide range of pH from 4.3 to 7.2. The wastewater was pumped at a fixed flow rate of 1m(3)h(-1) through the CSTR, the UASBAF and the MBR in series, resulting in respective HRTs of 12, 55 and 5h. Almost all the COD was removed by the TPAD-MBR system, leaving a COD of around 40 mg L(-1) in the MBR effluent. The pH of the MBR effluent was found in a narrow range of 6.8-7.6, indicating that the MBR effluent can be directly discharged into natural waters. A model, built on the back propagation neural network (BPNN) theory and linear regression techniques, was developed for the simulation of TPAD-MBR system performance in the biodegradation of chemical synthesis-based pharmaceutical wastewater. The model well fitted the laboratory data, and was able to simulate the removal of COD.

摘要

采用两相厌氧消化(TPAD)系统和后续膜生物反应器(MBR)对基于化学合成的制药废水进行了中试规模试验。TPAD系统包括一个连续搅拌釜式反应器(CSTR)和一个上流式厌氧污泥床-厌氧滤池(UASBAF),分别作为产酸相和产甲烷相。废水的化学需氧量(COD)很高,每天在5789至58792mg/L之间变化,pH值范围很广,从4.3到7.2。废水以1m³/h的固定流速串联泵入CSTR、UASBAF和MBR,各自的水力停留时间分别为12、55和5小时。TPAD-MBR系统几乎去除了所有的COD,MBR出水的COD约为40mg/L。发现MBR出水的pH值在6.8 - 7.6的狭窄范围内,这表明MBR出水可直接排放到天然水体中。基于反向传播神经网络(BPNN)理论和线性回归技术建立了一个模型,用于模拟TPAD-MBR系统对基于化学合成的制药废水生物降解的性能。该模型与实验室数据拟合良好,能够模拟COD的去除情况。

相似文献

1
A novel application of TPAD-MBR system to the pilot treatment of chemical synthesis-based pharmaceutical wastewater.TPAD-MBR系统在基于化学合成的制药废水试点处理中的新应用。
Water Res. 2008 Jul;42(13):3385-92. doi: 10.1016/j.watres.2008.04.020. Epub 2008 May 3.
2
Modeling of two-phase anaerobic process treating traditional Chinese medicine wastewater with the IWA Anaerobic Digestion Model No. 1.采用国际水协1号厌氧消化模型对两相厌氧工艺处理中药废水进行建模。
Bioresour Technol. 2009 Oct;100(20):4623-31. doi: 10.1016/j.biortech.2009.04.066. Epub 2009 May 23.
3
Anaerobic treatment of a chemical synthesis-based pharmaceutical wastewater in a hybrid upflow anaerobic sludge blanket reactor.在复合式上流式厌氧污泥床反应器中对基于化学合成的制药废水进行厌氧处理。
Bioresour Technol. 2008 Mar;99(5):1089-96. doi: 10.1016/j.biortech.2007.02.036. Epub 2007 Apr 20.
4
Application of a membrane bioreactor system for opto-electronic industrial wastewater treatment--a pilot study.膜生物反应器系统在光电工业废水处理中的应用——一项中试研究。
Water Sci Technol. 2003;48(8):195-202.
5
Back propagation neural network (BPNN) prediction model and control strategies of methanogen phase reactor treating traditional Chinese medicine wastewater (TCMW).反向传播神经网络 (BPNN) 预测模型与产甲烷相反应器处理中药废水 (TCMW) 的控制策略。
J Biotechnol. 2009 Oct 12;144(1):70-4. doi: 10.1016/j.jbiotec.2009.08.014. Epub 2009 Sep 2.
6
Performance and model of a full-scale up-flow anaerobic sludge blanket (UASB) to treat the pharmaceutical wastewater containing 6-APA and amoxicillin.处理含有 6-APA 和阿莫西林的制药废水的全尺寸上流式厌氧污泥床(UASB)的性能和模型。
J Hazard Mater. 2011 Jan 30;185(2-3):905-13. doi: 10.1016/j.jhazmat.2010.09.106. Epub 2010 Oct 7.
7
Membrane bioreactors for final treatment of wastewater.用于废水最终处理的膜生物反应器。
Water Sci Technol. 2003;48(8):103-10.
8
Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater.传统活性污泥法和膜生物反应器系统处理医院废水的出水水质
Environ Technol. 2006 Apr;27(4):395-402. doi: 10.1080/09593332708618651.
9
Herbal pharmaceutical wastewater treatment by a pilot scale upflow anaerobic sludge blanket (UASB) reactor.中试规模的上流式厌氧污泥床(UASB)反应器处理草药制药废水
Water Sci Technol. 2009;59(11):2265-72. doi: 10.2166/wst.2009.273.
10
MBR/RO/ozone processes for TFT-LCD industrial wastewater treatment and recycling.用于薄膜晶体管液晶显示器(TFT-LCD)工业废水处理与回用的膜生物反应器(MBR)/反渗透(RO)/臭氧工艺
Water Sci Technol. 2005;51(6-7):411-9.

引用本文的文献

1
Study on the removal characteristics and degradation pathways of highly toxic and refractory organic pollutants in real pharmaceutical factory wastewater treated by a pilot-scale integrated process.中试规模集成工艺处理实际制药厂废水中高毒性难降解有机污染物的去除特性及降解途径研究
Front Microbiol. 2023 Mar 9;14:1128233. doi: 10.3389/fmicb.2023.1128233. eCollection 2023.
2
Polymer Nanocomposite Membrane for Wastewater Treatment: A Critical Review.用于废水处理的聚合物纳米复合膜:综述
Polymers (Basel). 2022 Apr 24;14(9):1732. doi: 10.3390/polym14091732.
3
Inhibition effect of ethanol in naproxen degradation by catalytic ozonation with NiO.
乙醇对NiO催化臭氧化降解萘普生的抑制作用。
RSC Adv. 2019 May 14;9(26):14822-14833. doi: 10.1039/c9ra02133g. eCollection 2019 May 9.
4
Modification of Ceramic Membranes with Carbon Compounds for Pharmaceutical Substances Removal from Water in a Filtration-Adsorption System.用于在过滤吸附系统中从水中去除药物物质的含碳化合物改性陶瓷膜
Membranes (Basel). 2021 Jun 28;11(7):481. doi: 10.3390/membranes11070481.
5
Biosorption of dicloxacillin from pharmaceutical waste water using tannin from Indian almond leaf: Kinetic and equilibrium studies.利用印度扁桃树叶中的单宁对制药废水中双氯西林的生物吸附:动力学和平衡研究。
Biotechnol Rep (Amst). 2020 Jun 9;27:e00488. doi: 10.1016/j.btre.2020.e00488. eCollection 2020 Sep.